secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)
CIK:        0000315545
Form:       8-K
Filed at:   2026-02-02T23:59:59+00:00
Accession:  0001493152-26-004730
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Provectus extends automatic conversion date for Series D and D-1 preferred stock to Dec 2028
--------------------------------------------------------------------------------

- Automatic conversion date for Series D and D-1 preferred stock extended from June 20, 2026 to December 31, 2028.
- Amendments apply to Series D Convertible Preferred Stock and Series D-1 Convertible Preferred Stock, both par value $0.001.
- Board of directors and a special committee of independent directors approved the amendments.
- No changes to conversion terms other than the extension of the conversion date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/315545/000149315226004730/0001493152-26-004730-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/315545/000149315226004730/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-004730

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer